Portfolio Companies News
February 27, 2017Strongbridge Biopharma plc to Prese...
DUBLIN, Ireland and TREVOSE, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that Matthe... read more
February 24, 2017Company’s CEO Acquires Shares in ...
Stockholm, Sweden – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that the company’s CEO, Jakob Lindberg acquired 45,000 shares in Oncopeptides for a value of SEK 1.9M in addition to the shares that he subscribed for in the recent share issue in connection with the IPO. For f... read more
February 24, 2017Fusion Pharmaceuticals Launches wit...
HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the closing of a $25 million Series A financing led by founding venture investor, Johnson & Johnson I... read more
February 23, 2017Final Results from NICHE Phase III ...
23 February 2017 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today presented the final results of a multi-center Phase III trial in stroke rehabilitation (NICHE trial) assessing the Co... read more
February 23, 2017Wilson Theraputics AB (publ) Year-e...
Feb 23, 2017 Good year-end data gives a promising start to 2017 October 1 – December 31, 2016 Net sales amounted to SEK 0.0 M (0.0) Loss for the period was SEK 34.1 M (loss: 21.3) Loss per share, before and after dilution, totaled SEK 1.33 (loss: 16.84) At December 31, cash... read more
February 06, 2017Q4 2016 General Market Overview